Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme

Share this content:

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme

Sponsor and Collaborators     
M.D. Anderson Cancer Center
Celgene Corporation
 
Contact
Vinay K. Puduvalli, MD     
713-792-2883

Investigator
Vinay K. Puduvalli, MD     
M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier
NCT00671801

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs